This is a 2-part study evaluating ATV-1601 in participants with moderate to severe HHT. Part 1 is a randomized, double-blind, placebo-controlled study evaluati…

Hereditary Hemorrhagic Telangiectasia (HHT)Osler Weber Rendu Disease

~Estimated

~$10 – $8,750

Atavistik Bio, IncNCT07601425

Phase 1

A Phase I Trial of TOR-582, a Topical Sirolimus-based Treatment for Epistaxis in Adults With Hereditary Hemorrhagic Telangiectasia

People with hereditary hemorrhagic telangiectasia (HHT) often experience frequent and severe nosebleeds that can disrupt daily life and lead to anemia, medical…

Hereditary Hemorrhagic Telangiectasia (HHT)Epistaxis

~Estimated

~$10 – $6,250

Columbia UniversityNCT07667413